BioNTech SE

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.

About BNTX

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.

CEO

Ugur Sahin

CEOUgur Sahin

Employees

6,772

Employees6,772

Headquarters

Mainz, Rheinland-Pfalz

HeadquartersMainz, Rheinland-Pfalz

Founded

2008

Founded2008

Employees

6,772

Employees6,772

BNTX Key Statistics

Market cap

22.79B

Market cap22.79B

Price-Earnings ratio

-31.45

Price-Earnings ratio-31.45

Dividend yield

—

Dividend yield—

Average volume

746.62K

Average volume746.62K

High today

$96.01

High today$96.01

Low today

$93.72

Low today$93.72

Open price

$95.84

Open price$95.84

Volume

616.90K

Volume616.90K

52 Week high

$131.49

52 Week high$131.49

52 Week low

$76.53

52 Week low$76.53

BNTX News

TipRanks 6d

BioNTech SE’s BNT327 Shows Promising Results in SCLC, Earning a Buy Rating from Analyst

Leerink Partners analyst Daina Graybosch maintained a Buy rating on BioNTech SE (BNTX – Research Report) on March 21 and set a price target of $113.00. Daina G...

Analyst ratings

74%

of 23 ratings

Buy

73.9%

Hold

26.1%

Sell